Other products from "ORGANOGENESIS INC."
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 00618474000459 515-069 PuraPly™ Antimicrobial Wound Matrix consists of collagen sheets coated with poly PuraPly™ Antimicrobial Wound Matrix consists of collagen sheets coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
2 00618474000442 515-067 uraPly™ Antimicrobial Wound Matrix (fenestrated) consists of a collagen sheet co uraPly™ Antimicrobial Wound Matrix (fenestrated) consists of a collagen sheet coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
3 00618474000435 515-065 PuraPly™ Antimicrobial Wound Matrix consists of collagen sheets coated with poly PuraPly™ Antimicrobial Wound Matrix consists of collagen sheets coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
4 00618474000282 515-036 PuraPly™ Antimicrobial XT Wound Matrix consists of a collagen sheet coated with PuraPly™ Antimicrobial XT Wound Matrix consists of a collagen sheet coated with 0.1% polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial XT Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial XT Wound Matrix
5 00618474000121 515-020 PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with pol PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
6 00618474000039 1 PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with pol PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
7 00618474000008 1 Apligraf is indicated for use with standard therapeutic compression for the trea Apligraf is indicated for use with standard therapeutic compression for the treatment of non-infected partial and full thickness skin ulcers due to venous insufficience of greater than one month duration and which have not adequately responded to conventional ulcer therapy. Apligraf is also indicated for use with standard diabetic foot ulcer care for the treatment of full-thickness neuropathic diabetic foot ulcers of greater than three weeks duration which have not adequately responded to conventional ulcer therapy and which extend through the dermis but without tendon, muscle, capsule or bone exposure. PFC Cultured Human Cell Skin Dressing 3 Apligraf
8 00618474000046 10633 TRANSCYTE® is a human fibroblast-derived temporary skin substituteconsisting of TRANSCYTE® is a human fibroblast-derived temporary skin substituteconsisting of a polymer membrane and donated neonatal humanfibroblast cells cultured under aseptic conditions in vitro on a nylonmesh. Prior to cell growth, this nylon mesh is coated with porcinedermal collagen and bonded to a polymer membrane (silicone). Thismembrane provides a transparent synthetic epidermis when applied.As fibroblasts proliferate within the nylon mesh, they secrete humandermal collagen, matrix proteins and growth factors. Following freezing,no cellular metabolic activity remains; however, the tissue matrix andbound growth factors are left intact. The human fibroblast-derivedtemporary skin substitute provides a temporary protective barrier.TRANSCYTE is transparent and allows direct visual monitoring of thewound bed. MGR Dressing, Wound And Burn, Interactive 3 TransCyte
9 00618474000466 515-017 PuraPly™ Antimicrobial XT Wound Matrix consists of a collagen sheet coated with PuraPly™ Antimicrobial XT Wound Matrix consists of a collagen sheet coated with 0.1% polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial XT Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial XT Wound Matrix
10 00618474000275 515-034 515-034 PuraPly™ Antimicrobial XT Wound Matrix consists of a collagen sheet coated with PuraPly™ Antimicrobial XT Wound Matrix consists of a collagen sheet coated with 0.1% polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial XT Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. KMF Bandage, Liquid 1 PuraPly™ Antimicrobial XT Wound Matrix
11 00618474000114 515-018 PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with pol PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
12 00618474000107 515-008 PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with pol PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
13 00618474000091 515-016 PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with pol PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
14 00618474000084 515-014 PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with pol PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly™ Antimicrobial Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. FRO Dressing, Wound, Drug U PuraPly™ Antimicrobial Wound Matrix
15 00618474000237 550-008 PuraForce™ tendon reinforcement matrix is a resorbable collagen based material i PuraForce™ tendon reinforcement matrix is a resorbable collagen based material intended for implantation to reinforce soft tissue. The device is supplied sterile in double layer peel-open packaging. The product is packaged hydrated and is ready to use. PuraForce™ is intended for reinforcement of soft tissues repaired by sutures or suture anchors, during tendon repair surgery including reinforcement of rotator cuff, patellar, Achilles, biceps and quadriceps or other tendons.PuraForce™ is not intended to replace normal body structure or provide the full mechanical strength to support the rotator cuff, patellar, Achilles, biceps and quadriceps tendons. Sutures, used to repair the tear, and sutures or bone anchors, used to attach the tissue to the bone, provide biomechanical strength for the tendon repair. PuraForce reinforces soft tissue and provides a resorbable scaffold that is replaced by the patient’s own soft tissue. KGN Dressing, Wound, Collagen U PuraForce™
16 00618474000220 550-006 PuraForce ™ tendon reinforcement matrix is a resorbable collagen based material PuraForce ™ tendon reinforcement matrix is a resorbable collagen based material intended for implantation to reinforce soft tissue. The device is supplied sterile in double layer peel-open packaging. The product is packaged hydrated and is ready to use. PuraForce ™ is intended for reinforcement of soft tissues repaired by sutures or suture anchors, during tendon repair surgery including reinforcement of rotator cuff, patellar, Achilles, biceps and quadriceps or other tendons.PuraForce ™ is not intended to replace normal body structure or provide the full mechanical strength to support the rotator cuff, patellar, Achilles, biceps and quadriceps tendons. Sutures, used to repair the tear, and sutures or bone anchors, used to attach the tissue to the bone, provide biomechanical strength for the tendon repair. PuraForce reinforces soft tissue and provides a resorbable scaffold that is replaced by the patient’s own soft tissue. KGN Dressing, Wound, Collagen U PuraForce™
17 00618474000213 550-004 PuraForce ™ tendon reinforcement matrix is a resorbable collagen based material PuraForce ™ tendon reinforcement matrix is a resorbable collagen based material intended for implantation to reinforce soft tissue. The device is supplied sterile in double layer peel-open packaging. The product is packaged hydrated and is ready to use. PuraForce ™ is intended for reinforcement of soft tissues repaired by sutures or suture anchors, during tendon repair surgery including reinforcement of rotator cuff, patellar, Achilles, biceps and quadriceps or other tendons.PuraForce ™ is not intended to replace normal body structure or provide the full mechanical strength to support the rotator cuff, patellar, Achilles, biceps and quadriceps tendons. Sutures, used to repair the tear, and sutures or bone anchors, used to attach the tissue to the bone, provide biomechanical strength for the tendon repair. PuraForce reinforces soft tissue and provides a resorbable scaffold that is replaced by the patient’s own soft tissue. KGN Dressing, Wound, Collagen U PuraForce ™
18 00618474000206 550-002 PuraForce ™ tendon reinforcement matrix is a resorbable collagen based material PuraForce ™ tendon reinforcement matrix is a resorbable collagen based material intended for implantation to reinforce soft tissue. The device is supplied sterile in double layer peel-open packaging. The product is packaged hydrated and is ready to use. PuraForce ™ is intended for reinforcement of soft tissues repaired by sutures or suture anchors, during tendon repair surgery including reinforcement of rotator cuff, patellar, Achilles, biceps and quadriceps or other tendons.PuraForce ™ is not intended to replace normal body structure or provide the full mechanical strength to support the rotator cuff, patellar, Achilles, biceps and quadriceps tendons. Sutures, used to repair the tear, and sutures or bone anchors, used to attach the tissue to the bone, provide biomechanical strength for the tendon repair. PuraForce reinforces soft tissue and provides a resorbable scaffold that is replaced by the patient’s own soft tissue. KGN Dressing, Wound, Collagen U PuraForce™
19 00618474000077 515-012 PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen i PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen intended for the management of wounds. PuraPly™ Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. KGN Dressing, Wound, Collagen U PuraPly™ Wound Matrix
20 00618474000145 515-024 PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen i PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen intended for the management of wounds.PuraPly™ Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. KGN Dressing, Wound, Collagen U PuraPly™ Wound Matrix
21 00618474000060 515-006 PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen i PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen intended for the management of wounds. PuraPly™ Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. KGN Dressing, Wound, Collagen U PuraPly™ Wound Matrix
22 00618474000053 515-010 PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen i PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen intended for the management of wounds. PuraPly™ Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. KGN Dressing, Wound, Collagen PuraPly™ Wound Matrix
23 00618474000022 1 PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen i PuraPly™ Wound Matrix consists of a single-layer fenestrated sheet of collagen intended for the management of wounds. PuraPly™ Wound Matrix is supplied dry in sheet form. The device is packaged in sterile, sealed single pouches. KGN Dressing, Wound, Collagen U PuraPly™ Wound Matrix
Other products with the same Product Code "PFC"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 00618474000015 1 Dermagraft is indicated for use in the treatment of full-thickness diabetic foot Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than six weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Dermagraft should be used in conjunction with standard wound care regimens and in patients that have adequate blood supply to the involved foot. Dermagraft ORGANOGENESIS INC.
2 00618474000008 1 Apligraf is indicated for use with standard therapeutic compression for the trea Apligraf is indicated for use with standard therapeutic compression for the treatment of non-infected partial and full thickness skin ulcers due to venous insufficience of greater than one month duration and which have not adequately responded to conventional ulcer therapy. Apligraf is also indicated for use with standard diabetic foot ulcer care for the treatment of full-thickness neuropathic diabetic foot ulcers of greater than three weeks duration which have not adequately responded to conventional ulcer therapy and which extend through the dermis but without tendon, muscle, capsule or bone exposure. Apligraf ORGANOGENESIS INC.